HK1156605A1 - 作為雌激素相關受體調節劑的 -吡啶 嘧啶- -酮衍生物 - Google Patents

作為雌激素相關受體調節劑的 -吡啶 嘧啶- -酮衍生物

Info

Publication number
HK1156605A1
HK1156605A1 HK11110763.1A HK11110763A HK1156605A1 HK 1156605 A1 HK1156605 A1 HK 1156605A1 HK 11110763 A HK11110763 A HK 11110763A HK 1156605 A1 HK1156605 A1 HK 1156605A1
Authority
HK
Hong Kong
Prior art keywords
pyrido
pyrimidin
estrogen
modulators
derivatives
Prior art date
Application number
HK11110763.1A
Other languages
English (en)
Inventor
Ke Ding
Chiwai Wong
Lijie Peng
Zhanfang Kang
Xi Zhou
Original Assignee
Guangzhou Inst Of Biomedicine And Health Chin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Inst Of Biomedicine And Health Chin filed Critical Guangzhou Inst Of Biomedicine And Health Chin
Publication of HK1156605A1 publication Critical patent/HK1156605A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK11110763.1A 2008-07-18 2011-10-11 作為雌激素相關受體調節劑的 -吡啶 嘧啶- -酮衍生物 HK1156605A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2008100295869A CN101628913B (zh) 2008-07-18 2008-07-18 用作雌激素相关受体调节剂的化合物及其应用
PCT/CN2009/000243 WO2010006496A1 (zh) 2008-07-18 2009-03-06 用作雌激素相关受体调节剂的化合物及其应用

Publications (1)

Publication Number Publication Date
HK1156605A1 true HK1156605A1 (zh) 2012-06-15

Family

ID=41549998

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110763.1A HK1156605A1 (zh) 2008-07-18 2011-10-11 作為雌激素相關受體調節劑的 -吡啶 嘧啶- -酮衍生物

Country Status (9)

Country Link
US (2) US8853221B2 (zh)
EP (1) EP2314588B1 (zh)
JP (2) JP5749163B2 (zh)
CN (1) CN101628913B (zh)
AU (1) AU2009270363B2 (zh)
CA (1) CA2739379C (zh)
HK (1) HK1156605A1 (zh)
IL (1) IL211822A0 (zh)
WO (1) WO2010006496A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962546B2 (en) 2011-03-01 2015-02-24 Salk Institute For Biological Studies Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor
CN104119285B (zh) * 2013-04-28 2016-06-29 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
WO2018119374A1 (en) * 2016-12-22 2018-06-28 Cadent Therapeutics Nmda receptor modulators and uses thereof
LT3830092T (lt) 2018-08-03 2023-09-11 Novartis Ag Heteroaromatiniai nmda receptorių moduliatoriai ir jų panaudojimai
US20210228594A1 (en) * 2018-08-22 2021-07-29 Christina Theodoris Methods for treating cardiac valve disease
CN109820857A (zh) * 2019-03-27 2019-05-31 中国科学院广州生物医药与健康研究院 化合物dk45的新应用
EP4069694A1 (en) 2019-12-02 2022-10-12 Storm Therapeutics Ltd Polyheterocyclic compounds as mettl3 inhibitors

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11438A (en) * 1854-08-01 Car-wheel with independent flange and tread
US2007226A (en) * 1931-06-06 1935-07-09 Sinclair Refining Co Hydrogenation of hydrocarbons
US3169129A (en) * 1963-05-10 1965-02-09 American Cyanamid Co 2-ortho-hydroxy-phenyl-4-(3h)-quinazolinones
US3231572A (en) * 1963-08-05 1966-01-25 Miles Lab 3-substituted-4-quinazolones
US3268529A (en) * 1964-01-17 1966-08-23 Rexall Drug Chemical 3-cyanoalkyl substituted 4-(3h)-quinazolinones
FR1416418A (fr) 1964-09-09 1965-11-05 American Cyanamid Co Procédé pour émettre de la lumière fluorescente
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
HU180701B (en) * 1977-12-29 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing pyrido-/1,2-a/pyrimidines containing a carboxylic or ester group on the pirimidimering
EP0054132B1 (de) 1980-12-12 1984-10-10 Dr. Karl Thomae GmbH Neue Pyrimidinone, ihre Herstellung und Arzneimittel mit einem Gehalt an diesen Stoffen
US4431440A (en) * 1981-02-20 1984-02-14 American Cyanamid Company Method to alter or control the development and/or the life cycle of various plant species
DE3220898A1 (de) 1982-06-03 1983-12-08 Dr. Karl Thomae Gmbh, 7950 Biberach Verfahren zur herstellung von pyrimidinonen und ihren saeureadditionssalzen
DE3515882A1 (de) 1985-05-03 1986-11-06 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
TW274551B (zh) 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
CA2230237C (en) * 1995-08-30 2002-02-26 Kazuyoshi Miyata Process for preparing quinazolin-4-one derivative
US5783577A (en) * 1995-09-15 1998-07-21 Trega Biosciences, Inc. Synthesis of quinazolinone libraries and derivatives thereof
WO1997028149A1 (en) 1996-02-02 1997-08-07 Merck & Co., Inc. Method for raising hdl cholesterol levels
EP0946095A1 (en) 1996-12-17 1999-10-06 E.I. Du Pont De Nemours And Company Fungicidal quinazolinones
GB9702701D0 (en) * 1997-02-01 1997-04-02 Univ Newcastle Ventures Ltd Quinazolinone compounds
US5994367A (en) 1997-03-07 1999-11-30 The University Of North Carolina At Chapel Hill Method for treating tumors using 2-aryl-naphthyridin-4-ones
US5948775A (en) * 1997-03-19 1999-09-07 American Home Products Corporation 2- or 3-(substitutedaminoalkoxyphenyl)quinazolin-4-ones
GB9719411D0 (en) * 1997-09-12 1997-11-12 Ciba Geigy Ag New Pesticides
US6479499B1 (en) * 2000-06-28 2002-11-12 National Science Council 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
EP1341772A2 (en) 2000-12-11 2003-09-10 E. I. du Pont de Nemours and Company Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
CA2445697A1 (en) * 2001-04-26 2002-11-07 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
US20040110777A1 (en) * 2001-12-03 2004-06-10 Annis Gary David Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
US7381730B2 (en) * 2002-03-15 2008-06-03 Bristol-Myers Squibb Company 3-arylquinazoline derivatives as selective estrogen receptor beta modulators
GB2392558B (en) * 2002-08-30 2004-11-10 Tomy Co Ltd Electroluminescence light emitting display system and electroluminescence light emitting sheet
JP4691988B2 (ja) * 2002-10-03 2011-06-01 小野薬品工業株式会社 Ｌｐａ受容体拮抗剤
WO2004041755A2 (en) 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
EP1696927A4 (en) 2003-12-19 2007-10-31 Merck & Co Inc MITOTIC INHIBITORS OF KINESIN
EP1757594A4 (en) 2004-05-31 2007-12-12 Banyu Pharma Co Ltd quinazoline derivative
US20060012577A1 (en) * 2004-07-16 2006-01-19 Nokia Corporation Active keypad lock for devices equipped with touch screen
WO2006012577A2 (en) 2004-07-22 2006-02-02 Bayer Pharmaceuticals Corporation Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
DE102004048474A1 (de) * 2004-10-05 2006-04-06 Linde Ag Vorrichtung zum Wellenlöten
JP4890775B2 (ja) 2005-03-23 2012-03-07 パナソニック株式会社 発光モジュール
US7456188B1 (en) 2005-04-28 2008-11-25 Bristol-Myers Squibb Company C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators
US20070065662A1 (en) 2005-09-16 2007-03-22 Ludlow Coated Products Infrared activated thermoplastic bonding substrate
PT2118074E (pt) * 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
EP2079737A1 (en) * 2007-02-05 2009-07-22 Xenon Pharmaceuticals Inc. Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用

Also Published As

Publication number Publication date
US20150011544A1 (en) 2015-01-08
CN101628913B (zh) 2013-01-23
EP2314588B1 (en) 2014-11-05
CA2739379A1 (en) 2010-01-21
CA2739379C (en) 2016-05-03
WO2010006496A1 (zh) 2010-01-21
JP2011528322A (ja) 2011-11-17
AU2009270363A1 (en) 2010-01-21
JP5937642B2 (ja) 2016-06-22
EP2314588A4 (en) 2012-03-07
CN101628913A (zh) 2010-01-20
IL211822A0 (en) 2011-07-31
JP2014148557A (ja) 2014-08-21
US8853221B2 (en) 2014-10-07
US20110218196A1 (en) 2011-09-08
EP2314588A1 (en) 2011-04-27
AU2009270363B2 (en) 2014-03-13
JP5749163B2 (ja) 2015-07-15

Similar Documents

Publication Publication Date Title
IL204720A0 (en) Imidazo [1, 2 - a] pyridine derivatives useful as alk inhibitors
IL205341A0 (en) IMIDAZO [1, 2 - a] PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
IL204693A0 (en) Imidazo[1, 2 - a] pyrimidine derivatives for the treatment of diseases such as diabetes
ZA201101041B (en) 3h-imidazo [4,5-c] pyridine-6-carboxamides as anti-inflammatory agents
HK1183029A1 (zh) 作為 調節劑的吡唑並 嘧啶和噻吩並 嘧啶衍生物
PH12013501402A1 (en) Mesoionic Pyrido [1,2 -A] Pyrimidine Pesticides
IL200695A (en) History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them
HK1156605A1 (zh) 作為雌激素相關受體調節劑的 -吡啶 嘧啶- -酮衍生物
ZA201004524B (en) Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
ZA201004823B (en) Novel pyrazolo [3,4-d]pyrimidine derivatives as anti-cancer agents
IL215158A0 (en) Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
PL2124944T3 (pl) Pochodne pirazolo[3,4-b]pirydyny jako inhibitory fosfodiesterazy
ZA201005959B (en) 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives
EP2142542A4 (en) NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704
ZA201101861B (en) Compositions with and process for methylmorpholin-substituted pyrido [2,3-d] pyrimidines
IL211030A0 (en) Pyrazolo [5,1-b] oxazole derivatives as crf1 antagonists
ZA201009270B (en) Substituted pyrimido [2,1-a]isoquinolin-4-one derivatives
EP2139333A4 (en) SUBSTITUTED PYRIDO [3,2-E] [1,2,4] TRIAZOLO [4,3-C] PYRIMIDINE DERIVATIVES AS MODULATORS OF THE CANNABINOID-1 RECEPTOR
IL210708A0 (en) Imidazo [1,2-a]pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
IL198239A0 (en) Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a] pyrimidin -6- one and 8-piperidinyl-2- pyrimidinyl [1,2-a] pyrimidin -6- one derivatives
IL217294A0 (en) Novel 2,3 - dihydro -1h -imidazo (1,2-a)pyrimidin -5-one derivatives, preparation thereof, and pharamceutical use thereof
EP2139332A4 (en) SUBSTITUTED PYRIDO [2,3-D] PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS
EP2305678B8 (en) Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
ZA201008178B (en) Imidazo [2,1-b]quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
IL206666A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190309